The Clinical Trial Management System Market is expected to grow at a CAGR of 13.5% from 2023 to 2030 to reach $3.59 billion by 2030. The clinical trial management system (CTMS) enables efficient management of clinical trials, including time planning, trial subject recruitment, data capture and tracking, a database for investigators and research sites, billing compliance and budget management. The solution also integrates with other e-clinical applications providing visibility and transparency of clinical trial information.
The system gives access to the trial's accurate, up-to-date study information. It enables team members to collaborate on a single task of the same study. This assures that the members are accessing the latest data. The study sponsors and other stakeholders can also collaborate in the study. With the advancement in healthcare IT, the CTMS is upgrading with more integrations and in-built artificial intelligence (AI). For instance,
Pharmaceutical companies constantly focus on research and development (R&D), the core of drug development processes. The biotechnology industry also continues to witness substantial growth due to increased investments in R&D to cater to the growing demand for innovation and new medical breakthroughs. The importance of R&D is evident due to the rising number of drug approvals. For instance, in 2020, the FDA’s Center for Drug Evaluation and Research (CDER) approved 53 novel drugs, an increase from 48 novel drugs approved in 2019. High R&D investments in the life sciences sector is expected to drive the adoption of LIMS in the coming years, supporting the growth of the CTMS market.
Increasing R&D spending has boosted the demand for the efficient management of clinical trials. Most companies and CROs are using CTMS as it allows researchers to manage all activities related to the setup, conduction, and closeout of clinical trials. The system facilitates planning, preparation, monitoring, tracking, reporting, and compliance. Also, CTMS integrates with instruments or other in-lab systems to improve lab efficiency.
-Market.webp "Clinical Trial Management System (CTMS) Market")
Click here to: Get a Free Sample Copy of this report
Artificial Intelligence (AI) in Clinical Research Prevailing the Market Opportunity
Artificial Intelligence (AI) is expected to transform the clinical research industry. Advancements in software are transforming clinical studies. Advancements are improving, accelerating, and simplifying the clinical trial processes. Artificial Intelligence (AI) is helping in subject referral coding. Tracking study recruitment and analyzing and understanding results is cumbersome in nature. Herein, AI-powered referral coding reduces recruitment efforts. Subject referrals are automatically coded to specific campaigns. The CTMS study fosters notification when an individual has applied to the study link on the web. Thus, this also helps to identify the lead source.
AI also helps in automated follow-up and scheduling via email and text. This allows the clinical trial site to follow up with new leads. No-show rates are avoided due to text reminders and automated rescheduling notifications. Artificial Intelligence helps in financial and milestone tracking. AI automates screen-fail max and ratio identification with intuitive revenue and cost adjustment based on contract terms. This alerts the stakeholders whenever a milestone is completed in the clinical trial.
Based on component, the software segment is expected to account for the largest share of the market in 2023
The factors contributing to the largest market share are the increasing number of clinical trials, rising R&D expenditure, increased government support, rising prevalence of chronic diseases and the race to develop innovative and revolutionary clinical solutions. Clinical trials are carried out in different phases and require efficient management of every phase. CTMS helps in planning such activities, resulting in increased system adoption.
By type, the enterprise-based CTMS segment is expected to account for the largest share of the market and is projected to grow at the highest CAGR over the forecast period
Enterprise-based CTMS provides various advantages to the clinical trial site. The factors contributing to this segment's largest market share and fastest growth are robust reporting, enhanced billing compliance, efficient tracking, and management of regulatory processes.
Based on end user, the contract research organizations (CROs) segment is expected to account for the largest share of the market in 2023
The key factors attributing to the large market share are the rise in R&D activities, increased outsourcing of clinical trials to CROs due to various reasons such as the complex nature of the trial, monetary issues due to high investment, and incapability to conduct the clinical study.
Asia-Pacific: Estimated Highest CAGR Regional Market
Asia Pacific showcases the highest growth opportunities in the CTMS market owing to the increasing adoption of advanced laboratory informatics solutions, ease of regulatory compliance, large patient pool, presence of top clinical research institutions maintaining high-quality standards, and reduced cost of conducting studies. China, India, and Japan are leading in clinical trial services. India and China rank highest in population, proving a large patient pool. Also, the APAC region provides a genetically diverse population. Along with this, intellectual property protections are strongest in Singapore and Japan. Singapore supports clinical operations and supply chains through sophisticated transportation and communication infrastructure, regulatory framework, and an educated workforce. The APAC region also provides a skilled workforce experienced in conducting clinical trials. Peter MacCallum Cancer Center (Australia), Royal Children’s Hospital (Australia), Samsung Comprehensive Cancer Center at the Samsung Medical Center (South Korea), and world-renowned centers have a presence in the region.
Key Players
The report includes a competitive landscape based on an extensive assessment of the key strategic developments that led market participants to adopt over the past three years.The key players profiled in the global clinical trial management system (CTMS) market report are Oracle Corporation (U.S.), SimpleTrials (U.S.), LABORATORY CORPORATION OF AMERICA HOLDINGS (U.S.), Wipro Limited (India), Advarra, Inc. (U.S.), RealTime Software Solutions, LLC (U.S.), Datatrak International, Inc. (U.S.), Clario (U.S.), Dassault Systèmes (France), Veeva Systems Inc. (U.S.), PHARMASEAL (U.K.), MasterControl Inc. (U.S.), Calyx (U.S.), IQVIA HOLDINGS INC. (U.S.), and DSG, Inc. (U.S.) among others.
Scope of the Report:
Clinical Trial Management System (CTMS) Market, by Component
Clinical Trial Management System (CTMS) Market, by Type
Clinical Trial Management System (CTMS) Market, by Mode of Delivery
Clinical Trial Management System (CTMS) Market, by End User
Clinical Trial Management System Market, by Geography
Key questions answered in the report:
This study offers a detailed assessment of the clinical trial management system market, including the market size & forecast for various segmentation like component, type, mode of delivery, and end user. The clinical trial management system market studied in this report also involves the value analysis of various segments and sub-segments of clinical trial management systems at regional and country levels.
The global clinical trial management system market is projected to reach $3.59 billion by 2030, at a CAGR of 13.5% during the forecast period.
Based on type, the enterprise-based CTMS segment is expected to grow at the highest CAGR over the forecast period. Ease of customization, end-to-end insights into operational activities, and tracking and administration of regulatory processes will enhance the demand for enterprise-based CTMS.
The growth of this market is mainly attributed to the surge in the number of clinical trials, increasing adoption of healthcare IT, and rising government support. Moreover, artificial intelligence (AI) in clinical research will offer significant opportunities for market growth.
The key players profiled in the global clinical trial management system market are Oracle Corporation (U.S.), SimpleTrials (U.S.), LABORATORY CORPORATION OF AMERICA HOLDINGS (U.S.), Wipro Limited (India), Advarra, Inc. (U.S.), RealTime Software Solutions, LLC (U.S.), Datatrak International, Inc. (U.S.), Clario (U.S.), Dassault Systèmes (France), Veeva Systems Inc. (U.S.), PHARMASEAL (U.K.), MasterControl Inc. (U.S.), Calyx (U.S.), IQVIA HOLDINGS INC. (U.S.), and DSG, Inc. (U.S.) among others.
Emerging economies in the Asia-Pacific region are projected to offer significant growth opportunities to the market players due to the rising adoption of CTMS and the increasing patient population are driving the market growth in this region.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for this Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Surge in Number of Clinical Trials
4.2.2. Increasing Adoption of Healthcare IT Solutions
4.2.3. Rising Government Support
4.3. Restraints
4.3.1. Budget Constraints
4.3.2. Concerns Over Data Privacy & Security
4.4. Opportunities
4.4.1. Artificial Intelligence (AI) Based CTMS
4.5. Challenges
4.5.1. Unavailability of Skilled Professionals
4.6. Impact of COVID-19 on the CTMS Market
4.7. Trend: Inclination of Companies Towards Integrated CTMS Solutions
5. Clinical Trial Management System (CTMS) Market, by Component
5.1. Introduction
5.2. Software
5.3. Service
6. Clinical Trial Management System (CTMS) Market, by Type
6.1. Introduction
6.2. Enterprise-based
6.3. Site-based
7. Clinical Trial Management System (CTMS) Market, by Mode of Delivery
7.1. Introduction
7.2. Web-based CTMS
7.3. Cloud-based CTMS
7.4. On-premise CTMS
8. Clinical Trial Management System (CTMS) Market, by End User
8.1. Introduction
8.2. Contract Research Organizations (CROs)
8.3. Pharmaceutical & Biotechnology Companies
8.4. Medical Device Companies
8.5. Other End Users
(Note: Other end users include hospitals, academic Institutions, and animal health companies, among others)
9. Clinical Trial Management System (CTMS) Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
9.6. Middle East & Africa
10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Market Share Analysis (2022)
11. Company Profiles (Business Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)
11.1. Oracle Corporation (U.S.)
11.2. SimpleTrials (U.S.)
11.3. LABORATORY CORPORATION OF AMERICA HOLDINGS (U.S.)
11.4. Wipro Limited (India)
11.5. Advarra, Inc. (U.S.)
11.6. RealTime Software Solutions, LLC (U.S.)
11.7. Datatrak International, Inc. (U.S.)
11.8. Clario (U.S.)
11.9. Dassault Systèmes (France)
11.10. Veeva Systems Inc. (U.S.)
11.11. PHARMASEAL (U.K.)
11.12. MasterControl Inc. (U.S.)
11.13. Calyx (U.S.)
11.14. IQVIA HOLDINGS INC. (U.S.)
11.15. DSG, Inc. (U.S.)
11.16. Other Companies
12. Appendix
12.1. Questionnaire
12.2. Available Customization
List of Tables
Table 1 Global Clinical Trial Management System Market: Impact Analysis of Market Drivers (2023–2030)
Table 2 Global Clinical Trial Management System Market: Impact Analysis of Market Restraints (2023–2030)
Table 3 Global Clinical Trial Management System Size, by Component, 2021–2030 (USD Million)
Table 4 Global Clinical Trial Management System Software Market Size, by Country/Region, 2021–2030 (USD Million)
Table 5 Global Clinical Trial Management System Service Market Size, by Country/Region, 2021–2030 (USD Million)
Table 6 Global Clinical Trial Management System Size, by Type, 2021–2030 (USD Million)
Table 7 Global Clinical Trial Management System Enterprise-based Market Size, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Clinical Trial Management System Site-based Market Size, by Country/Region, 2021–2030 (USD Million)
Table 9 Global Clinical Trial Management System Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 10 Global Web-based Clinical Trial Management System Market Size, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Cloud-based Clinical Trial Management System Market Size, by Country/Region, 2021–2030 (USD Million)
Table 12 Global On-premise Clinical Trial Management System Market Size, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Clinical Trial Management System Size, by End User, 2021–2030 (USD Million)
Table 14 Global Clinical Trial Management System Market Size for Contract Research Organizations, by Country/Region,2021–2030 (USD Million)
Table 15 Global Clinical Trial Management System Market Size for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021–2030 (USD Million)
Table 16 Global Clinical Trial Management System Market Size for Medical Device Companies, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Clinical Trial Management System Market Size for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Clinical Trial Management System Market Size, by Country/Region, 2021–2030 (USD Million)
Table 19 North America: Clinical Trial Management System Market Size, by Country, 2021–2030 (USD Million)
Table 20 North America: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 21 North America: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 22 North America: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 23 North America: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 24 U.S.: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 25 U.S.: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 26 U.S.: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 27 U.S.: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 28 Canada: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 29 Canada: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 30 Canada: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 31 Canada: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 32 Europe: Clinical Trial Management System Market Size, by Country, 2021–2030 (USD Million)
Table 33 Europe: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 34 Europe: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 35 Europe: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 36 Europe: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 37 Germany: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 38 Germany: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 39 Germany: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 40 Germany: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 41 France: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 42 France: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 43 France: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 44 France: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 45 U.K.: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 46 U.K.: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 47 U.K.: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 48 U.K.: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 49 Italy: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 50 Italy: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 51 Italy: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 52 Italy: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 53 Spain: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 54 Spain: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 55 Spain: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 56 Spain: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 57 RoE: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 58 RoE: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 59 RoE: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 60 RoE: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 61 Asia-Pacific: Clinical Trial Management System Market Size, by Country, 2021–2030 (USD Million)
Table 62 Asia-Pacific: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 63 Asia-Pacific: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 64 Asia-Pacific: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 65 Asia-Pacific: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 66 China: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 67 China: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 68 China: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 69 China: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 70 Japan: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 71 Japan: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 72 Japan: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 73 Japan: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 74 India: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 75 India: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 76 India: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 77 India: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 78 Rest of Asia-Pacific: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 79 Rest of Asia-Pacific: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 80 Rest of Asia-Pacific: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 81 Rest of Asia-Pacific: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 82 Latin America: Clinical Trial Management System Market Size, by Country, 2021–2030 (USD Million)
Table 83 Latin America: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 84 Latin America: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 85 Latin America: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 86 Latin America: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 87 Brazil: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 88 Brazil: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 89 Brazil: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 90 Brazil: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 91 Mexico: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 92 Mexico: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 93 Mexico: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 94 Mexico: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 95 Rest of Latin America: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 96 Rest of Latin America: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 97 Rest of Latin America: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 98 Rest of Latin America: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 99 Middle East & Africa: Clinical Trial Management System Market Size, by Component, 2021–2030 (USD Million)
Table 100 Middle East & Africa: Clinical Trial Management System Market Size, by Type, 2021–2030 (USD Million)
Table 101 Middle East & Africa: Clinical Trial Management System Market Size, by Mode of Delivery, 2021–2030 (USD Million)
Table 102 Middle East & Africa: Clinical Trial Management System Market Size, by End User, 2021–2030 (USD Million)
Table 103 Recent Developments, by Company (2020–2022)
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Global Clinical Trial Management System Size, by Component, 2023 Vs. 2030 (USD Million)
Figure 8 Global Clinical Trial Management System Size, by Type, 2023 Vs. 2030 (USD Million)
Figure 9 Global Clinical Trial Management System Size, by Mode of Delivery, 2023 Vs. 2030 (USD Million)
Figure 10 Global Clinical Trial Management System Size, by End User, 2023 Vs. 2030 (USD Million)
Figure 11 Clinical Trial Management System Market, by Region
Figure 12 Market Dynamics
Figure 13 Global Clinical Trial Management System Size, by Component, 2023 Vs. 2030 (USD Million)
Figure 14 Global Clinical Trial Management System Size, by Type, 2023 Vs. 2030 (USD Million)
Figure 15 Global Clinical Trial Management System Size, by Mode of Delivery, 2023 Vs. 2030 (USD Million)
Figure 16 Global Clinical Trial Management System Size, by End User, 2023 Vs. 2030 (USD Million)
Figure 17 Global Clinical Trial Management System Size, by Region, 2023 Vs. 2030 (USD Million)
Figure 18 North America: Clinical Trial Management System Snapshot
Figure 19 Europe: Clinical Trial Management System Snapshot
Figure 20 Asia-Pacific: Clinical Trial Management System Snapshot
Figure 21 Latin America: Clinical Trial Management System Snapshot
Figure 22 Market Share Analysis: Clinical Trial Management System Market, 2022
Figure 23 Oracle Corporation: Financial Overview, 2022
Figure 24 LABORATORY CORPORATION OF AMERICA HOLDINGS: Financial Overview, 2022
Figure 25 Wipro Limited: Financial Overview, 2022
Figure 26 Datatrak International, Inc.: Financial Overview, 2022
Figure 27 Dassault Systèmes: Financial Overview, 2022
Figure 28 Veeva Systems Inc.: Financial Overview, 2022
Figure 29 IQVIA HOLDINGS INC.: Financial Overview, 2022
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Feb-2023
Published Date: Sep-2022
